RxDoctor Payments Data
★ My doctorsLook up a doctor →

Gbolabo Sokunbi, MD

Orthopaedic Surgery · New York, NYNPI 1992039044

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (47.0%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. Stryker accounts for 61.6% of it on its own, with 18 other manufacturers making up the rest. Reporting peaked in 2024 at $8,330 and has fallen 74.6% since, to $2,112 in 2025.

$33,821in general payments, 2019–2025

Across 111 payments — averaging $304.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$21K
  • The Institute Of Musculoskeletal Science And Education$4K
  • Camber Spine Technologies LLC$3K
  • Degen Medical, Inc.$2K
  • Globus Medical$1K
  • Alphatec Spine, Inc$760
  • plus $2K from 13 others
$8,510in research payments, 2019–2025

Across 5 payments — averaging $1702.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Bioventus LLC$9K
$18,738in ownership & investment interests, 2019–2025

Across 7 payments — averaging $2676.87 each. An ownership or investment interest held by the physician or an immediate family member.

  • Amplify Surgical, Inc.$19K

What the payments were for

  • Royalty or licence$1,6675%
  • Consulting fees$15,88547%
  • Travel & lodging$8,68226%
  • Food & beverage$5,64217%
  • Education$1,9446%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Stryker59$20,844
The Institute Of Musculoskeletal Science And Education6$4,473
Camber Spine Technologies LLC7$2,567
Degen Medical, Inc.5$1,722
Globus Medical4$1,265
Alphatec Spine, Inc5$760
Augmedics Inc.4$318
Kuros Biosciences USA, Inc1$288
Cerapedics Inc.2$268
Arteriocyte Medical Systems, Inc.2$237
Si-bone, Inc.2$223
Johnson & Johnson3$177
Medical Device Business Services, Inc.3$176
Orthofix Medical, Inc.1$143
Terumo BCT, Inc.2$120
Medtronic(2 entities)2$113
VB Spine LLC1$60
Zimmer Biomet1$38
Centinel Spine, LLC1$28

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$33,821 in reported general payments places this provider in the 80th percentile of 1,079 orthopaedic surgery providers in New York.

See all orthopaedic surgery providers in New York →

Medicare billing

Part B allowed, 2024
$372,106
Medicare patients
476
Services billed
1,122

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin108$703
Oxycodone Hcl35$245
Diclofenac Sodium14$194
Duloxetine Hcl14$177
Pregabalin13$176
Methylprednisolone20$162
Tizanidine Hcl11$126
Methocarbamol17$74
Tramadol Hcl16$42
Meloxicam12$31

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in New York

See the full list for New York →

Where these figures come from

Is this you, or does something look wrong? →